2jog Citations

Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.

Structure 15 587-97 (2007)
Cited: 36 times
EuropePMC logo PMID: 17502104

Abstract

Calcineurin (Cn) is a serine/threonine protein phosphatase that plays pivotal roles in many physiological processes, including cell proliferation, development, and apoptosis. Most prominently, Cn targets the nuclear factors of activated T cell (NFATs), transcription factors that activate cytokine genes. Calcium-activated Cn dephosphorylates multiple residues within the regulatory domain of NFAT, triggering joint nuclear translocation. This relies crucially on the interaction between the catalytic domain of Cn (CnCat) and the conserved PxIxIT motif located in a region distinct from the dephosphorylation sites of NFAT. Here, we present the structure of the complex between the 39 kDa CnCat and a 14 residue peptide containing a PVIVIT segment that was derived from affinity-driven peptide selection based on the conserved PxIxIT motif of NFATs. The structure of the complex was determined by using NMR assignments and structural constraints and the coordinates of the CnCat crystal structure. The NMR analysis relied on recently developed labeling and spectroscopic techniques. The VIVIT peptide is accommodated in a hydrophobic cleft formed by beta strands 11 and 14, and the loop between beta strands 11 and 12, forming a short parallel beta sheet with the exposed beta strand 14 in Cn. The side chains of conserved residues in the PxIxIT sequences make extensive interactions with conserved residues in Cn, while those of nonconserved residues are solvent exposed. The architecture of the interface explains the diversity of recognition sequences compatible with NFAT function and uncovers a potential targeting site for immune-suppressive agents. The structure reveals that the orientation of the bound PxIxIT directs the phosphorylation sites in NFAT's regulatory domain toward the Cn catalytic site.

Articles - 2jog mentioned but not cited (3)

  1. NMR resonance assignments of the catalytic domain of human serine/threonine phosphatase calcineurin in unligated and PVIVIT-peptide-bound states. Takeuchi K, Sun ZY, Li S, Gal M, Wagner G. Biomol NMR Assign 9 201-205 (2015)
  2. Cis-trans proline isomers in the catalytic domain of calcineurin. Teixeira JMC, Guasch A, Biçer A, Aranguren-Ibáñez Á, Chashmniam S, Paniagua JC, Pérez-Riba M, Fita I, Pons M. FEBS J 286 1230-1239 (2019)
  3. Funneling modulatory peptide design with generative models: Discovery and characterization of disruptors of calcineurin protein-protein interactions. Tubiana J, Adriana-Lifshits L, Nissan M, Gabay M, Sher I, Sova M, Wolfson HJ, Gal M. PLoS Comput Biol 19 e1010874 (2023)


Reviews citing this publication (10)

  1. Serine/threonine phosphatases: mechanism through structure. Shi Y. Cell 139 468-484 (2009)
  2. The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Arkin MR, Whitty A. Curr Opin Chem Biol 13 284-290 (2009)
  3. Short linear motifs - ex nihilo evolution of protein regulation. Davey NE, Cyert MS, Moses AM. Cell Commun Signal 13 43 (2015)
  4. Nuclear factor of activated T cells in cancer development and treatment. Shou J, Jing J, Xie J, You L, Jing Z, Yao J, Han W, Pan H. Cancer Lett 361 174-184 (2015)
  5. The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases. Kipanyula MJ, Kimaro WH, Seke Etet PF. J Aging Res 2016 5081021 (2016)
  6. Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands. Galat A. Cell Mol Life Sci 70 3243-3275 (2013)
  7. Detection of intermolecular NOE interactions in large protein complexes. Anglister J, Srivastava G, Naider F. Prog Nucl Magn Reson Spectrosc 97 40-56 (2016)
  8. Recent progress on the structure of Ser/Thr protein phosphatases. Wang B, Zhang P, Wei Q. Sci China C Life Sci 51 487-494 (2008)
  9. Transient disorder: Calcineurin as an example. Creamer TP. Intrinsically Disord Proteins 1 e26412 (2013)
  10. Targeting CaN/NFAT in Alzheimer's brain degeneration. Mackiewicz J, Lisek M, Boczek T. Front Immunol 14 1281882 (2023)

Articles citing this publication (23)